Fasting Plasma Glucose in Type 2 Diabetes

Elevated. Studies summarised in the OSMF atlas report higher Fasting Plasma Glucose in Type 2 Diabetes than in the reference group of the cited comparison (T2D vs healthy/non-diabetic individuals). Source: Smushkin et al. 2010.

The atlas record does not list a standardised clinical test code (LOINC) for Fasting Plasma Glucose, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

No. No single biomarker is diagnostic of Type 2 Diabetes. Fasting Plasma Glucose findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

No. The same marker is also reported in Type 1 Diabetes in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.